XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net income $ 61,832 $ 46,165
(Income) loss from discontinued operations (770) 80
Income from continuing operations 61,062 46,245
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 8,293 9,451
Amortization of operating lease assets 7,216 6,948
Depreciation 10,296 9,803
Amortization of acquired intangible assets 2,805 2,805
Amortization and write-off of debt discount and issuance costs 1,145 1,113
Provision for bad debts 14,883 13,720
Deferred income taxes 54,413 16,456
Loss on disposals and impairments of property and equipment 2 107
Gain on investments (680) (613)
Changes in assets and liabilities:    
Accounts and financing receivables (62,690) (56,803)
Prepaid expenses and other current assets (29,841) (7,389)
Cloud computing implementation assets (4,812) (7,888)
Accounts payable 1,378 (8,508)
Accrued payroll and benefits (24,359) (21,501)
Accrued liabilities (12,287) (8,467)
Deferred revenue 109,082 106,156
Operating lease liabilities (4,317) (7,232)
Other assets and liabilities (960) (4,836)
Net cash provided by operating activities-continuing operations 130,629 89,567
Net cash used in operating activities-discontinued operations (80) (251)
Net cash provided by operating activities 130,549 89,316
Investing activities:    
Capital expenditures (16,023) (10,414)
Proceeds from sales of marketable securities 100 2,187
Purchases of marketable securities (100) (1,308)
Net cash used in investing activities (16,023) (9,535)
Financing activities:    
Proceeds from exercise of stock options 131 9,498
Employee taxes paid on withholding shares (39,119) (10,717)
Proceeds from stock issued under Colleague Stock Purchase Plan 411 298
Repurchases of common stock for treasury (7,595) (33,190)
Proceeds from issuance of long-term debt   9,873
Repayments of long-term debt   (9,873)
Payment of debt issuance costs (3,333) 0
Net cash used in financing activities (49,505) (34,111)
Net increase in cash, cash equivalents and restricted cash 65,021 45,670
Cash, cash equivalents and restricted cash at beginning of period 201,164 221,202
Cash, cash equivalents and restricted cash at end of period 266,185 266,872
Non-cash investing and financing activities:    
Accrued capital expenditures 4,727 4,193
Accrued liability for repurchases of common stock   800
Accrued excise tax on share repurchases 1,630 3,259
Accrued debt issuance costs $ 437 $ 0